We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+7.05%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$131B
AUM Growth
+$13.8B
(+12%)
Cap. Flow
+$6.04B
Cap. Flow
% of AUM
4.61%
Top 10 Holdings %
Top 10 Hldgs %
44.72%
Holding
4,042
New
364
Increased
2,601
Reduced
814
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$740M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$544M |
| 3 |
NVIDIA
NVDA
|
+$407M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$325M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$276M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$232M |
| 2 |
Vanguard Large-Cap ETF
VV
|
+$58.3M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$46.4M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$40M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$37.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.26% |
| 2 | Financials | 3.77% |
| 3 | Consumer Discretionary | 2.12% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
New Mountain Finance
NMFC
$646M
| $139K | ﹤0.01% |
14,393
+684
| +5% | +$7.09K |
|
3602
Invesco Advantage Municipal Income Trust II
VKI
$394M
| $138K | ﹤0.01% |
15,792
+4,132
| +35% | +$34.7K |
|
3603
Evolus
EOLS
$394M
| $138K | ﹤0.01% |
+22,549
| New | +$176K |
|
3604
Braskem
BAK
$980M
| $137K | ﹤0.01% |
56,790
+33,614
| +145% | +$108K |
|
3605
Altimmune
ALT
$539M
| $137K | ﹤0.01% |
36,378
-4,786
| -12% | -$18.5K |
|
3606
Definitive Healthcare
DH
$72.1M
| $137K | ﹤0.01% |
33,678
+5,050
| +18% | +$20.2K |
|
|
CTLP
3607
DELISTED
Cantaloupe
CTLP
| $137K | ﹤0.01% |
12,933
-15,305
| -54% | -$167K |
|
3608
MeiraGTx Holdings
MGTX
$1.09B
| $137K | ﹤0.01% |
16,586
+3,815
| +30% | +$30.2K |
|
3609
AtaiBeckley Inc
ATAI
$2.66B
| $136K | ﹤0.01% |
25,760
+7,528
| +41% | +$30.6K |
|
3610
Titan International
TWI
$516M
| $136K | ﹤0.01% |
18,010
+433
| +2% | +$3.86K |
|
|
BLNE
3611
Beeline Holdings
BLNE
$30.6M
| $136K | ﹤0.01% |
34,357
| – | – |
|
|
MCW
3612
DELISTED
Mister Car Wash
MCW
| $136K | ﹤0.01% |
25,458
+12,528
| +97% | +$73.8K |
|
3613
Blend Labs
BLND
$409M
| $135K | ﹤0.01% |
37,099
+3,063
| +9% | +$11K |
|
|
BRSP
3614
BrightSpire Capital
BRSP
$681M
| $135K | ﹤0.01% |
24,820
+14,011
| +130% | +$76.2K |
|
|
VNET
3615
VNET Group
VNET
$2.05B
| $135K | ﹤0.01% |
13,044
-251
| -2% | -$2.11K |
|
3616
Latham Group
SWIM
$646M
| $134K | ﹤0.01% |
17,602
+3,836
| +28% | +$28.2K |
|
3617
Empire State Realty Series ES
ESBA
$1.47B
| $134K | ﹤0.01% |
17,977
| – | – |
|
3618
Recursion Pharmaceuticals
RXRX
$1.57B
| $133K | ﹤0.01% |
27,318
-8,902
| -25% | -$46.8K |
|
3619
Ardagh Metal Packaging
AMBP
$2.86B
| $133K | ﹤0.01% |
33,360
+7,889
| +31% | +$31.4K |
|
|
ESPR
3620
DELISTED
Esperion Therapeutics
ESPR
| $132K | ﹤0.01% |
+49,913
| New | +$96.5K |
|
3621
Fulcrum Therapeutics
FULC
$248M
| $132K | ﹤0.01% |
14,354
-2,585
| -15% | -$18.7K |
|
3622
Noodles & Co
NDLS
$90.5M
| $131K | ﹤0.01% |
25,839
| – | – |
|
3623
Certara
CERT
$1.17B
| $131K | ﹤0.01% |
+10,713
| New | +$117K |
|
3624
Orion Group Holdings
ORN
$514M
| $131K | ﹤0.01% |
15,720
-6,546
| -29% | -$51.6K |
|
3625
ImmunityBio
IBRX
$7.44B
| $131K | ﹤0.01% |
53,143
-8,885
| -14% | -$22.9K |
|
Similar funds
Creative Planning's Q3 2025 Portfolio in Review
As of Q3 2025, Creative Planning held 4,042 positions worth $131B, up 12% from $117B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning deployed $6.04B of net new capital in Q3 2025, opening 364 new positions and adding to 2,601 existing holdings. Its largest new stake was Amrize Ltd: 170,878 shares worth $8.29M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $232M trimmed.
- Creative Planning's largest Q3 2025 buy was Amrize Ltd: 170,878 shares worth $8.29M.
- Creative Planning added most to Vanguard Total Bond Market in Q3 2025, an estimated $740M increase.
- Creative Planning's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $232M.
- Creative Planning fully exited Ansys in Q3 2025, selling an estimated $4.86M.
- Creative Planning's ten largest holdings make up 45% of its $131B portfolio in Q3 2025.
- Creative Planning opened 364 new positions and closed 133 in Q3 2025.
- Creative Planning's portfolio value rose 12% quarter-over-quarter to $131B.
Based on Creative Planning's 13F filing for Q3 2025, filed 14 Nov 2025.